Basic Information
ID: ALA5033951
Type: Functional
Description: Agonist activity at human RXFP3 expressed in human CHO-K1 cells assessed as maximal inhibition of forskolin-induced cAMP accumulation measured after 1.5 hrs by TR-FRET assay relative to relaxin 3
Organism: Homo sapiens
Cell type: CHO-K1
Activity Charts
Bioactivity
Activity Types for Assay ALA5033951
Emax
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 383.88 | 3.78 | 3.78 |
| 383.88 | 3.83 | 3.83 |
| 418.33 | 4.48 | 4.48 |
| 407.47 | 2.96 | 2.96 |
| 350.43 | 2.57 | 2.57 |
| 383.88 | 3.83 | 3.83 |
| 369.86 | 3.52 | 3.52 |
| 383.88 | 3.83 | 3.83 |
| 475.33 | 3.78 | 3.78 |
| 379.46 | 3.18 | 3.18 |
| 364.84 | 3.38 | 3.38 |
| 350.43 | 2.57 | 2.57 |
| 353.86 | 3.82 | 3.82 |
| 355.83 | 4.11 | 4.11 |
| 355.47 | 3.24 | 3.24 |
| 378.87 | 3.69 | 3.69 |
| 394.44 | 3.08 | 3.08 |
| 367.43 | 3.31 | 3.31 |
| 353.86 | 3.82 | 3.82 |
| 369.86 | 3.52 | 3.52 |
| 369.86 | 3.52 | 3.52 |
| 397.87 | 3.30 | 3.30 |
| 397.91 | 4.08 | 4.08 |
| 388.48 | 3.30 | 3.30 |
| 353.86 | 3.82 | 3.82 |
| 392.51 | 3.24 | 3.24 |
| 383.88 | 3.86 | 3.86 |
| 353.86 | 3.82 | 3.82 |
| 383.88 | 3.53 | 3.53 |
| 397.91 | 4.22 | 4.22 |
| 369.86 | 3.52 | 3.52 |
| 381.46 | 3.57 | 3.57 |
| 357.82 | 3.65 | 3.65 |
| 465.73 | 4.12 | 4.12 |
| 364.45 | 2.82 | 2.82 |
| 428.33 | 3.94 | 3.94 |
| 357.82 | 3.65 | 3.65 |
| 339.83 | 3.51 | 3.51 |
| 383.88 | 3.86 | 3.86 |
| 383.88 | 3.91 | 3.91 |
| 484.91 | 3.73 | 3.73 |
| 349.44 | 3.18 | 3.18 |
| 350.43 | 2.57 | 2.57 |
| 374.28 | 4.17 | 4.17 |
| 402.46 | 2.83 | 2.83 |
| 357.82 | 3.65 | 3.65 |
| 357.82 | 3.65 | 3.65 |
| 418.73 | 4.27 | 4.27 |
| 370.84 | 3.71 | 3.71 |
| 499.88 | 2.83 | 2.83 |
| 363.47 | 3.48 | 3.48 |
| 369.86 | 3.79 | 3.79 |
| 384.83 | 3.42 | 3.42 |
| 355.47 | 3.24 | 3.24 |
| 359.44 | 2.69 | 2.69 |
| 374.45 | 3.05 | 3.05 |